Binding of estrogens to serum protein of rats treated with hepatocarcinogenic compounds.
D000081:Acetamides / Q000009:adverse effects; D000510:Alpha-Globulins / Q000494:pharmacology*; D000818:Animals; D001202:Ascitic Fluid; D001345:Autoradiography; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000503:physiopathology*; D002499:Centrifugation, Density Gradient; D002850:Chromatography, Gel; D003956:Dialysis; D004591:Electrophoresis, Polyacrylamide Gel; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D005326:Fetal Proteins / Q000494:pharmacology*; D005449:Fluorenes / Q000009:adverse effects; D007106:Immune Sera; D007122:Immunoelectrophoresis; D008113:Liver Neoplasms / Q000139:chemically induced / Q000503:physiopathology*; D008297:Male; D008722:Methods; D011485:Protein Binding; D051381:Rats; D004124:p-Dimethylaminoazobenzene / Q000009:adverse effects
D000081:Acetamides; D000510:Alpha-Globulins; D004967:Estrogens; D005326:Fetal Proteins; D005449:Fluorenes; D007106:Immune Sera; D004124:p-Dimethylaminoazobenzene